Citations

Clear

13603 citation(s) found for "_, _".

The Anesthesia & Analgesia Strategy for the “People and Health Advocacy” Section: Economic, Academic, and Healthcare Dividends of Diversity, Equity, and Inclusion
Milam, Adam J. , Milam, Adam J , Pandit, Jaideep J.

Mayo Clinic

Anesthesia & Analgesia | February 28, 2025 | Volume: 140 | Issue: 5 | Pages: 1093-1098

10.1213/ane.0000000000007468 | PMID 40019858 Get It

Design, Implementation, and Evaluation of a Multidisciplinary Palliative Care Curriculum for Obstetrician Gynecologist Residents
Thannickal, Aneesa , Alston, Meredith , Amory, Josephine, Kumar, Amanika, Lefkowits, Carolyn , Brubaker, Lindsay W. , Moroney, Marisa R. , Kumar, Amanika

Mayo Clinic

Palliative Medicine Reports | February 28, 2025 | Volume: 6 | Issue: 1 | Pages: No page available

10.1089/pmr.2024.0082 | PMID 40171212 Get It

Purpose: Palliative care focuses on providing relief from the stress and symptoms of serious illness. Obstetrician gynecologists (OBGYNs) manage a variety of complex clinical situations ranging from delivering a cancer diagnosis to caring for a neonatal demise to symptom management, all of which fall within the realm of palliative care. Palliative care is relevant to the practice of OBGYNs, yet residents rarely receive formal primary palliative care training. We sought to design, implement, and evaluate a dedicated curriculum on palliative care for OBGYN residents. Methods: We performed a needs assessment of an OBGYN residency at a single institution. This information was used to develop a multidisciplinary palliative care curriculum. Post-curriculum surveys were distributed and analyzed. Descriptive statistics were utilized. Results: Our needs assessment identified a lack of knowledge and competency in palliative care concepts and skills. Using this information, we created a multidisciplinary palliative care curriculum, including clinical experiences, chalk talks, and online didactics. Post-curriculum surveys revealed a marked improvement in both knowledge base and perceived competence. Feedback was overwhelmingly positive; residents indicated that the curriculum was both a valuable use of time and would impact their provision of care in the future. Conclusion: A dedicated palliative care curriculum is an impactful addition to OBGYN training.
Plasma TREM2 Levels, Alcohol Consumption, and Liver Enzymes in Patients with Alcohol use Disorder: A Sex-Dependent Relationship Involving MS4A6A Genetic Polymorphism
Skime, Michelle , Hu, Li , Weinshilboum, Richard, Coombes, Brandon, Oesterle, Tyler , Ho, Ming‐Fen , Zhang, Cheng , Coombes, Brandon J. , Biernacka, Joanna M. , Croarkin, Paul E. , Karpyak, Victor M. , Li, Hu

Mayo Clinic

Journal of Proteomics and Genomics Research | February 28, 2025 | Volume: 2 | Issue: 3 | Pages: 18-32

10.14302/issn.2326-0793.jpgr-25-5405 | PMID 41552371 Get It

Alcohol use disorder (AUD) is the most prevalent substance use disorder. Excessive alcohol consumption leads to a range of health issues. We set out to identify inflammatory markers linked to alcohol consumption, which might ultimately offer novel insight into genetic underpinnings and have implications for alcohol-associated disease. Alcohol consumption and blood-based multi-omics data were collected by The Mayo Clinic Center for Individualized Treatment of Alcohol Dependence study. Plasma samples from patients with AUD were used for proteomics analysis using the OLINK “Explore Inflammation” panel (n=410). Liver enzymes were also measured. A genome-wide association study (GWAS) was performed to explore the relationship between genetic variants and plasma TREM2 levels. Our findings show thatplasma triggering receptor expressed on myeloid cells 2 (TREM2), a key gene associated with neurodegenerative disease, was the most significant signal correlated with alcohol consumption, and has also been associated with liver enzyme levels in patients with AUD. We identified the rs7232 single nucleotide polymorphism (SNP) in MS4A6A as a key genetic variant associated with plasma TREM2 levels, with the minor allele (A) linked to higher TREM2 levels and increased alcohol consumption, particularly in men. Furthermore, MA4A6A is an ethanol-responsive gene in a SNP-dependent manner, and the variant genotype of the rs7232 SNP was associated with lower expression for MA4A6A due to proteasome-mediated protein degradation. In summary, this study provides insight into the relationship between plasma TREM2 levels, alcohol consumption, and liver function in AUD patients, shedding light on genetic factors underlying alcohol-related diseases.
End points and outcomes in follicular lymphoma: what should we measure, how, and why?
Di, Mengyang , Maurer, Matthew J. , Flowers, Christopher R. , Maurer, Matthew , Di, Mengyang

Mayo Clinic

Blood | February 28, 2025 | Volume: 146 | Issue: 15 | Pages: 1802-1811

10.1182/blood.2024026978 | PMID 40019453 Get It

Abstract Overall survival (OS) and quality of life (QoL) are clinically relevant outcomes/end points during examination of therapies. However, with median OS approaching 20 years for patients with follicular lymphoma (FL), it is often not feasible to use OS as a primary end point in clinical studies. Although validated tools exist for assessing QoL in patients with lymphoma, QoL data are rarely the sole basis for drug approvals in FL. Therefore, other survival end points, surrogates, and intermediate clinical end points have all been used to measure outcomes in FL trials. In this review, we discuss the strengths and limitations of these commonly used traditional end points in FL trials and examine the current gaps, including delayed availability of results and suboptimal sensitivity in distinguishing difference in therapeutic effects. To help address the identified gaps, well-validated surrogates, such as complete remission 30 months after starting frontline immunochemotherapy, may be used as the primary or co-primary end point in confirmatory randomized trials. Emerging intermediate end points like minimal residual disease may be useful in early phase trials and in guiding accelerated approvals after appropriate validation. As patient preference plays a crucial role in treatment decisions in FL, it is critical to include QoL as an important secondary trial end point and to measure nonmedical burdens, including time and financial toxicities. End points that are clinically relevant, timely, and patient-centered may identify new drugs that help patients with FL live longer and better lives.
Bibliometric analysis of artificial intelligence applications in cardiovascular imaging: trends, impact, and emerging research areas
Alotaibi, Abdulhadi , Contreras, Rafael, Thakker, Nisarg, Mahapatro, Abinash , Jala, Saisree Reddy Adla, Mohanty, Elan, Devulapally, Pavan , Mirchandani, Mohit, Jain, Shika M , Asl, Azin Alizadeh, Jebelli, Seyedeh Fatemeh Hosseini , Amini‐Salehi, Ehsan , Ameen, Daniyal, Marsool Marsool, Mohammed Dheyaa, Contreras, Rafael, Marsool, Mohammed Dheyaa Marsool , Joukar, Farahnaz

Mayo Clinic

Annals of Medicine & Surgery | February 27, 2025 | Volume: 87 | Issue: 4 | Pages: 1947-1968

10.1097/ms9.0000000000003080 | PMID 40212204 Get It

Background: The application of artificial intelligence (AI) in cardiac imaging has rapidly evolved, offering enhanced accuracy and efficiency in the diagnosis and management of cardiovascular diseases. This bibliometric study aimed to evaluate research trends, impact, and scholarly output in this expanding field. Methods: A systematic search was conducted on 14 August 2024 using the Web of Science Core Collection database. VOSviewer, CiteSpace, and Biblioshiny were utilized for data analysis. Results: The findings revealed a significant increase in publications on AI in cardiovascular imaging, particularly from 2018 to 2023, with the United States leading in research output. England and the United States have emerged as central hubs in the global research network, highlighting their role in generating high-quality and impactful publications. The University of London was identified as the top contributing institution, while Frontiers in Cardiovascular Medicine was the most prolific journal. Keyword analysis highlighted machine learning, echocardiography, and diagnosis as the most frequently occurring terms. A time trend analysis showed a shift in research focus toward AI applications in cardiac computed tomography (CT) and magnetic resonance imaging (MRI), with recent keywords like ejection fraction, risk, and heart failure reflecting emerging areas of interest. Conclusion: Healthcare providers should consider integrating AI tools into cardiovascular imaging practice, as AI has demonstrated the potential to enhance diagnostic accuracy and improve patient outcomes. This study highlights the rising importance of AI in personalized and predictive cardiovascular care, urging healthcare providers to stay informed about these advancements to enhance clinical decision-making and patient management.
Escalation of Oxygenation Modalities and Mortality in Critically Ill Immunocompromised Patient With Acute Hypoxemic Respiratory Failure: A Clustering Analysis of a Prospectively Multicenter, Multinational Dataset
Yvin, Élise, Kouatchet, Achille, Mokart, Djamel, Martín‐Loeches, Ignacio , Seguin, Amélie, Louw, Andry van de, Mabrouki, Asma, Bredin, Swann, Klouche, Kada , Mehta, Sangeeta , Bruneel, Fabrice , Lisboa, Tiago, Viana, William, Pickkers, Peter , Russell, Lene , Rusínová, Kateřina , Rello, Jordi, Clère-Jehl, Raphaël , Lafarge, Antoine , Lemiale, Virginie , Mercat, Alain , Russell, Lene , Martin-Loeches, Ignacio , Kouatchet, Achille, Mokart, Djamel , Taccone, Fabio Silvio , Pène, Frédéric , Bauer, Philippe R. , Seguin, Amélie, Metaxa, Victoria , Montini, Luca , Lisboa, Tiago, Rello, Jordi , Barbier, Francois, Azoulay, Élie , Darmon, Michaël

Mayo Clinic

Critical Care Medicine | February 27, 2025 | Volume: 53 | Issue: 5 | Pages: e1055-e1065

10.1097/ccm.0000000000006600 | PMID 40013850 Get It

OBJECTIVES: Acute hypoxemic respiratory failure in immunocompromised patients remains the leading cause of admission to the ICU, with high case fatality. The response to the initial oxygenation strategy may be predictive of outcome. This study aims to assess the response to the evolutionary profiles of oxygenation strategy and the association with survival. DESIGN: Post hoc analysis of EFRAIM study with a nonparametric longitudinal clustering technique (longitudinal K-mean). SETTING AND PATIENTS: Multinational, observational prospective cohort study performed in critically ill immunocompromised patients admitted for an acute respiratory failure. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: A total of 1547 patients who did not require invasive mechanical ventilation (iMV) at ICU admission were included. Change in ventilatory support was assessed and three clusters of change in oxygenation modality over time were identified. Cluster A: 12.3% iMV requirement and high survival rate, n = 717 patients (46.3%); cluster B: 32.9% need for iMV, 97% ICU mortality, n = 499 patients (32.3%); and cluster C: 37.5% need for iMV, 0.3% ICU mortality, n = 331 patients (21.4%). These clusters demonstrated a high discrimination. After adjustment for confounders, clusters B and C were independently associated with need for iMV (odds ratio [OR], 9.87; 95% CI, 7.26–13.50 and OR, 19.8; 95% CI, 13.7–29.1). CONCLUSIONS: This study identified three distinct highly performing clusters of response to initial oxygenation strategy, which reliably predicted the need for iMV requirement and hospital mortality.
Use and safety of corticosteroid injections in joints and musculoskeletal soft tissue: guidelines from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, the American Society of Interventional Pain Physici
Benzon, Honorio T. , Provenzano, David , Nagpal, Ameet , Souza, Dmitri , Eckmann, Maxim , Nelson, Ariana M. , Mina, Maged, Elmofty, Dalia , Pino, Carlos A. , Rana, Maunak V., Shah, Shalini , Stout, Alison , Smith, Elizabeth Reichert , Hirsch, Joshua A , Schneider, Byron J. , Manchikanti, Laxmaiah , Maus, Timothy P. , Rivera, Jessica , FitzGerald, John , Provenzano, David Anthony , Chadwick, Andrea , Doshi, Tina L , Pino, Carlos A , Shankar, Hariharan , Cohen, Steven P , Narouze, Samer , Shanthanna, Harsha , Hunt, Christine , Benzon, Honorio T , Nagpal, Ameet S , FitzGerald, John D , Nelson, Ariana M , Abd-Elsayed, Alaa A , Doshi, Tina L , Shankar, Hariharan , Smith, Elizabeth, Abdi, Salahadin , Cohen, Steven P. , Narouze, Samer , Shanthanna, Harsha , Wasan, Ajay D. , Hoang, Thanh D , Rivera, Jessica

Mayo Clinic

Regional Anesthesia & Pain Medicine | February 27, 2025 | Volume: 51 | Issue: 7 | Pages: 746-773

10.1136/rapm-2024-105656 | PMID 40015722 Get It

Background Intra-articular corticosteroid (IACS) injection and peri-articular corticosteroid injection are commonly used to treat musculoskeletal conditions. Results vary by musculoskeletal region, but most studies report short-term benefit with mixed results on long-term relief. Publications showed adverse events from single corticosteroid injections. Recommended effective doses were lower than those currently used by clinicians. Methods Development of the practice guideline for joint injections was approved by the Board of Directors of the American Society of Regional Anesthesia and Pain Medicine and the participating societies. A Corticosteroid Safety Work Group coordinated the development of three guidelines: peripheral nerve blocks and trigger points; joints; and neuraxial, facet, and sacroiliac joint injections. The topics included safety of the technique in relation to landmark-guided, ultrasound-guided, or radiology-aided injections; effect of the addition of the corticosteroid on the efficacy of the injectate; and adverse events related to the injection. Experts on the topics were assigned to extensively review the literature and initially develop consensus statements and recommendations. A modified version of the US Preventive Services Task Force grading of evidence and strength of recommendation was followed. A modified Delphi process was adhered to in arriving at a consensus. Results This guideline focuses on the safety and efficacy of corticosteroid joint injections for managing joint chronic pain in adults. The joints that were addressed included the shoulder, elbow, hand, wrist, hip, knee, and small joints of the hands and feet. All the statements and recommendations were approved by all participants and the Board of Directors of the participating societies after four rounds of discussion. There is little evidence to guide the selection of one corticosteroid over another. Ultrasound guidance increases the accuracy of injections and reduces procedural pain. A dose of 20 mg triamcinolone is as effective as 40 mg for both shoulder IACS and subacromial subdeltoid bursa corticosteroid injections. The commonly used dose for hip IACS is 40 mg triamcinolone or methylprednisolone. Triamcinolone 40 mg is as effective as 80 mg for knee IACS. Overall, IACS injections result in short-term pain relief from a few weeks to a few months. The adverse events include an increase in blood glucose, adrenal suppression, detrimental effect on cartilage lining the joint, reduction of bone mineral density, and postoperative joint infection. Conclusions In this practice guideline, we provided specific recommendations on the role of corticosteroids in joint, bursa, and peritendon injections for musculoskeletal pain.
Infrapatellar branch of saphenous nerve: from anatomy, sonoanatomy to its clinical implications
Peng, Michael SJ , Clendenen, Steven R. , Tsui, Ban C H , Clendenen, Steven R , Shi, Glenn G. , Tsui, Ban C. H.

Mayo Clinic

Regional Anesthesia & Pain Medicine | February 27, 2025 | Volume: 51 | Issue: 4 | Pages: 465-472

10.1136/rapm-2025-106383 | PMID 40015723 Get It

The infrapatellar branch of the saphenous nerve (IPBSN) is implicated in nerve injury from different knee surgeries because of its intimate course relative to the knee joint capsule. Pain physicians encounter patients in their practice for the management of neuralgia of this nerve or in the context of advanced management of knee osteoarthritis. This article aims to provide a comprehensive review of the anatomy, sonoanatomy, and the intervention of the IPBSN in pain management of infrapatellar neuralgia and chronic knee pain.
Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression Subtypes
Collin, Lindsay J. , Cushing‐Haugen, Kara L. , Terry, Kathryn L. , Goode, Ellen L. , Wu, Anna H. , Harris, Holly R. , Sasamoto, Naoko , Cramer, Daniel W. , Modugno, Francesmary , Elishaev, Esther , Moysich, Kirsten B. , Fasching, Peter A. , Pearce, Celeste Leigh , Menon, Usha , Gayther, Simon A. , Wentzensen, Nicolas , Goodman, Marc T. , George, Joshy , Talhouk, Aline , Anglesio, Michael S. , Ramus, Susan J. , Bowtell, David D.L. , Tworoger, Shelley S. , Schildkraut, Joellen M. , George, Joshy , Fu, Zhuxuan , Moysich, Kirsten , Fasching, Peter A , Pearce, Celeste Leigh , Menon, Usha , Gentry‐Maharaj, Aleksandra , Gayther, Simon A , Wentzensen, Nicolas , Goodman, Marc T , George, Joshy , Talhouk, Aline , Anglesio, Michael S , Ramus, Susan J , Bowtell, David D , Tworoger, Shelley S , Schildkraut, Joellen M , Webb, Penelope M , Doherty, Jennifer A , Cramer, Daniel W , Modugno, Francesmary , Harris, Holly R , Elishaev, Esther , Cushing-Haugen, Kara L , Fu, Zhuxuan , Webb, Penelope M. , Doherty, Jennifer A.

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | February 26, 2025 | Volume: 34 | Issue: 5 | Pages: 762-773

10.1158/1055-9965.epi-24-1143 | PMID 40009771 Get It

Abstract Background: Ovarian high-grade serous carcinomas (HGSC) comprise four distinct molecular subtypes based on mRNA expression patterns, with differential survival. Understanding risk factor associations is important to elucidate the etiology of HGSC. We investigated associations between different epidemiologic risk factors and HGSC molecular subtypes. Methods: We pooled data from 11 case–control studies with epidemiologic and tumor gene expression data from custom NanoString CodeSets developed through a collaboration within the Ovarian Tumor Tissue Analysis consortium. The PrOTYPE-validated NanoString-based 55-gene classifier was used to assign HGSC gene expression subtypes. We examined associations between epidemiologic factors and HGSC subtypes in 2,070 cases and 16,633 controls using multivariable-adjusted polytomous regression models. Results: Among the 2,070 HGSC cases, 556 (27%) were classified as C1.MES, 340 (16%) as C5.PRO, 538 (26%) as C2.IMM, and 636 (31%) as C4.DIF. The key factors, including oral contraceptive use, parity, breastfeeding, and family history of ovarian cancer, were similarly associated with all subtypes. Heterogeneity was observed for several factors. Former smoking [OR = 1.25; 95% confidence interval (CI) = 1.03, 1.51] and genital powder use (OR = 1.42; 95% CI = 1.08, 1.86) were uniquely associated with C2.IMM. History of endometriosis was associated with C5.PRO (OR = 1.46; 95% CI = 0.98, 2.16) and C4.DIF (OR = 1.27; 95% CI = 0.94, 1.71) only. Family history of breast cancer (OR = 1.44; 95% CI = 1.16, 1.78) and current smoking (OR = 1.40; 95% CI = 1.11, 1.76) were associated with C4.DIF only. Conclusions: This study observed heterogeneous associations of epidemiologic and modifiable factors with HGSC molecular subtypes. Impact: The different patterns of associations may provide key information about the etiology of the four subtypes.
Uremic Toxins, CKD, and Cognitive Dysfunction
Andrews, Taylor , Day, Gregory S. , Irani, Sarosh R. , Kanekiyo, Takahisa , Hickson, LaTonya J. , Andrews, Taylor D , Irani, Sarosh R , Hickson, LaTonya J , Day, Gregory S

Mayo Clinic

Journal of the American Society of Nephrology | February 26, 2025 | Volume: 36 | Issue: 6 | Pages: 1208-1226

10.1681/asn.0000000675 | PMID 40009460 Get It

Cognitive impairment involves alterations to one's cognitive status that affects everyday life. Individuals with CKD, and particularly kidney failure, experience higher rates of cognitive impairment (20%–70%) compared with the general population. The highest prevalence is described in kidney failure such that dialysis-dependent patients have twice the prevalence of age-matched controls. In the past 5 years, the number of investigations examining the “kidney-brain axis,” mechanisms of CKD-related cognitive impairment, and potential therapeutics have exponentially increased. This review article summarizes recent literature on direct and indirect effects of CKD-associated cognitive impairment with emphasis on uremic toxins; brain injury mechanisms; overlap between CKD-associated cognitive impairment, Alzheimer's disease, and other neurodegenerative diseases. Reviewed therapeutic interventions include AST-120 (indoxyl sulfate absorbent), CH-223191 (aryl hydrocarbon receptor antagonist), triarylmethane-34 (Kca3.1-specific inhibitor), anakinra (IL-1R inhibitor), marimastat, exercise, supplements, and kidney transplantation. Special focus is placed on translational studies examining uremic toxin–associated pathogenic processes, including brain oxidative stress, neuroinflammation, and blood-brain barrier dysfunction through in vitro and in vivo models of CKD-associated brain injury. Finally, future research directions are suggested, including targeting of cellular senescence abundance with senotherapeutics and capitalizing on anti-inflammatory effects of regenerative, cell-based therapeutics ( e.g ., mesenchymal stem cells and extracellular vesicles), and use of aged murine models. Collectively, CKD-associated cognitive impairment represents a prevalent condition for which remaining knowledge gaps exist, and scientific advancements are needed to preserve cognitive function and improve the lives of individuals with CKD.